ERNA ▲ +10.4% - Ernexa Therapeutics Inc.
$ERNA - Ernexa Therapeutics Reports Compelling ERNA-101 Safety Results Across Three Critical IND-Enabling Studies, Advancing Toward Planned Q4 2026 IND
30-SEP-2026 08:32 AM ET
Share this post
More filings for $ERNA
ERNA ▼ -9.9% - Ernexa Therapeutics Inc.Oct 12, 2026ERNA ▼ -2.5% - Ernexa Therapeutics Inc.Oct 6, 2026ERNA ▼ -0.9% - Ernexa Therapeutics Inc.Oct 1, 2026ERNA ▲ +5.2% - Ernexa Therapeutics Inc.Sep 29, 2026ERNA ▲ +5.1% - Ernexa Therapeutics Inc.Sep 17, 2026ERNA ▼ -18.0% - Ernexa Therapeutics Inc.Sep 15, 2026
View full $ERNA filing history →💬 Comments
Loading comments…
Leave a comment